The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 ...

The World Health Organization (WHO) said on Monday that it has signed a $1.5 billion primary health financing platform with ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

Let’s talk about insider trading. Not the illegal kind, but the perfectly normal – and fully legal – trading by top-level ...

Revenue forecast for the pharmaceutical market in the Asia-Pacific region in 2023, by country (in billion U.S. dollars) Characteristic Revenue in billion U.S. dollars ...

Pharmaceutical market revenue in the Asia-Pacific region from 2019 to 2023, with forecasts to 2028, by segment (in billion U.S. dollars) ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, has embarked on its ...

This Lectureship recognises an outstanding emerging investigator working on an energy research topic within the scope of Energy & Environmental Science, providing a platform to showcase their research ...

Energy is an exciting, multidisciplinary research area, bringing together chemistry, physics, materials science, engineering, computer science, and techno-economical ...

Indian shares were set to open at record highs on Tuesday, tracking gains in Asian peers, and extending their rally after the ...

Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030MUMBAI, India, Sept. 16, 2024 ...